Tolka AI Therapeutics
PrivateLast Round
Seed
Jun 13, 2024
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Tolka AI Therapeutics operates in Healthcare & Life Sciences and is based in Dublin. It was founded in 2022.
Tolka AI Therapeutics is a biotechnology company that has developed an AI-based platform for drug discovery for complex inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Drug Discovery
Business Model
B2B2C
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tolka AI Therapeutics Comparables
Compare Tolka AI Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioPhoundry | 79% | |
| Medea Biopharma | 73% | |
| Locus Biosciences | 73% |
For institutional investors. Book with your work email.
Tolka AI Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Tolka AI Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Khosla Ventures | Angel |
| NIH RADx | Angel |
| Draper Associates | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 438% MoM, reaching 10.7K.
- Feb 3, 2026
Monthly visitors increased 269% MoM.
For institutional investors. Book with your work email.
Tolka AI Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Tolka AI Therapeutics's valuation, stock price, and market status.
Is Tolka AI Therapeutics a public or private company?
Tolka AI Therapeutics is a private company.
What is the current stock price of Tolka AI Therapeutics?
Tolka AI Therapeutics is a private company, so its shares have no public market price. Caplight tracks Tolka AI Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Tolka AI Therapeutics worth (valuation)?
Valuation information for Tolka AI Therapeutics is not publicly available.
Can I buy Tolka AI Therapeutics stock?
Tolka AI Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Tolka AI Therapeutics's last funding round?
Tolka AI Therapeutics's most recent funding round was Seed on June 13, 2024.
Who are the main investors in Tolka AI Therapeutics?
Key investors in Tolka AI Therapeutics include Khosla Ventures, NIH RADx, Draper Associates.
Will Tolka AI Therapeutics IPO soon?
No public IPO plans have been announced for Tolka AI Therapeutics.
How can I track Tolka AI Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Tolka AI Therapeutics's shares on secondary markets.